166 related articles for article (PubMed ID: 9592182)
1. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression.
Yasui W; Kudo Y; Naka K; Fujimoto J; Ue T; Yokozaki H; Tahara E
Int J Oncol; 1998 Jun; 12(6):1253-8. PubMed ID: 9592182
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
Koyama S; Maruyama T; Adachi S
J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.
Yasui W; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
Virchows Arch; 1996 Sep; 429(1):13-9. PubMed ID: 8865848
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
[TBL] [Abstract][Full Text] [Related]
7. CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.
Go SI; Ko GH; Lee WS; Kim RB; Lee JH; Jeong SH; Lee YJ; Hong SC; Ha WS
Cancer Res Treat; 2016 Jan; 48(1):142-52. PubMed ID: 25779358
[TBL] [Abstract][Full Text] [Related]
8. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
[TBL] [Abstract][Full Text] [Related]
9. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression.
Yasui W; Akama Y; Yokozaki H; Semba S; Kudo Y; Shimamoto F; Tahara E
Pathol Int; 1997 Jul; 47(7):470-7. PubMed ID: 9234386
[TBL] [Abstract][Full Text] [Related]
10. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
[TBL] [Abstract][Full Text] [Related]
11. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Maeta N; Osaki M; Shomori K; Inaba A; Kidani K; Ikeguchi M; Ito H
Oncology; 2007; 73(1-2):118-26. PubMed ID: 18337624
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
[TBL] [Abstract][Full Text] [Related]
13. CD44 variant isoform 9 emerges in response to injury and contributes to the regeneration of the gastric epithelium.
Bertaux-Skeirik N; Wunderlich M; Teal E; Chakrabarti J; Biesiada J; Mahe M; Sundaram N; Gabre J; Hawkins J; Jian G; Engevik AC; Yang L; Wang J; Goldenring JR; Qualls JE; Medvedovic M; Helmrath MA; Diwan T; Mulloy JC; Zavros Y
J Pathol; 2017 Aug; 242(4):463-475. PubMed ID: 28497484
[TBL] [Abstract][Full Text] [Related]
14. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori-Infected CAPZA1-Overexpressing Cells.
Tsugawa H; Kato C; Mori H; Matsuzaki J; Kameyama K; Saya H; Hatakeyama M; Suematsu M; Suzuki H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):319-334. PubMed ID: 31146068
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.
Zheng HC; Tsuneyama K; Takahashi H; Miwa S; Sugiyama T; Popivanova BK; Fujii C; Nomoto K; Mukaida N; Takano Y
J Cancer Res Clin Oncol; 2008 Apr; 134(4):481-8. PubMed ID: 17876606
[TBL] [Abstract][Full Text] [Related]
17. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas].
Zheng J; Zhu Y; Li C; Li Y; Nie Q; Zhu Z; Deng H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):335-341. PubMed ID: 27868405
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa.
Ishimoto T; Izumi D; Watanabe M; Yoshida N; Hidaka K; Miyake K; Sugihara H; Sawayama H; Imamura Y; Iwatsuki M; Iwagami S; Baba Y; Horlad H; Komohara Y; Takeya M; Baba H
J Gastroenterol; 2015 Jul; 50(7):751-7. PubMed ID: 25479940
[TBL] [Abstract][Full Text] [Related]
20. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma.
Singhi AD; Lazenby AJ; Montgomery EA
Am J Surg Pathol; 2012 Jul; 36(7):1030-5. PubMed ID: 22472957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
